GTS Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-55,200
Closed -$3.76M 2192
2024
Q3
$3.76M Buy
55,200
+11,600
+27% +$655K 0.01% 1097
2024
Q2
$1.84M Sell
43,600
-177,000
-80% -$9.74M ﹤0.01% 1561
2024
Q1
$15.2M Buy
220,600
+153,800
+230% +$9.73M 0.03% 346
2023
Q4
$4.94M Buy
66,800
+600
+0.9% +$39.3K 0.01% 1015
2023
Q3
$4.52M Buy
+66,200
New +$5.62M 0.01% 984

Other funds holding EXAS

GTS Securities's EXAS Position: Q4 2025 in Review

GTS Securities sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 5,063 shares — an estimated $277K sold.

GTS Securities first reported a position in EXAS in Q2 2023 and held it in 8 quarters. The position peaked at $6.58M in Q4 2023. 710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • GTS Securities reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • GTS Securities sold 5,063 Exact Sciences shares in Q4 2025, an estimated $277K.
  • GTS Securities first reported a position in Exact Sciences in Q2 2023 and held it in 8 quarters.
  • GTS Securities's Exact Sciences position peaked at $6.58M in Q4 2023.
  • 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.